Genoa acquires Northeast Pharmaceuticals

Genoa said on Wednesday that it has purchased Northeast Pharmaceuticals (NEP). Financial terms were not disclosed.

“The addition of NEP to Genoa brings together two providers of specialty behavioral health pharmacy services into one organization committed to a common mission,” Genoa CEO John Figueroa said. “The combination adds to a company that can truly make a positive impact on the lives of individuals with a mental illness and those that care for them. Our collective history of providing excellent service makes this a terrific addition and a win for all of our constituencies, including our clients and consumers, and our center partners.”

With this acquisition, Genoa said it will be able to provide behavioral health and pharmacy services to individuals in 37 states and the D.C. area. Both companies serve approximately 25 million customers through specialized pharmacy services at behavioral health centers and through the supply of prescribed medication.

Genoa Healthcare merged with QoL Medicine in 2014, becoming Genoa, a QoL Healthcare Company, providing services to both individual patients and health care organizations.

Together, NEP and Genoa employ approximately 1,600 people. NEP was founded in 2005 and has become a leading provider of custom pharmacy services, operating eight pharmacies in thee states in the Southeastern U.S.